A review of recent clinical trials paints a sobering picture of the usefulness of first-line psychotherapies in treating active duty military personnel and veterans with Post-Traumatic Stress Disorder (PTSD).
Led by researchers at NYU Grossman School of Medicine and recently published in the Journal of the American Medical Association (JAMA) Insights , the article summarizes findings of recently conducted clinical trials of two well-established, first-line cognitive-behavioral psychotherapies - Prolonged Exposure Therapy (PE) and Cognitive Processing Therapy (CPT) -- to treat PTSD.
The researchers conclude that clinical trials of these treatment modalities show limited effectiveness for treating PTSD in active duty military personnel and veterans.
The review also reports that for military service related PTSD, more emotionally demanding therapies like PE and CPT, which repeatedly activate and process memories of traumatic experiences, were not more beneficial than interventions which do not require patients to focus on their traumatic events, including present-centered therapy (a supportive, problem-solving treatment), transcendental meditation and biological treatments such as anti-depressants.
Cognitive behavioral therapy's limited value for treating military service related PTSD suggests the need to go beyond the one-size-fits-all approaches rolled out in most VA and DoD healthcare settings and personalize treatment, accounting for pre-service vulnerabilities and complex, repeated exposures to warzone stressors." Charles R. Marmar, MD, senior author, the Lucius Littauer Professor and Chair of Psychiatry at NYU Grossman School of Medicine Related Stories
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology